Assessment of the safety, efficacy, PK, and extrapulmonary pharmacodynamics (PD) of Albuterol Sulfate Pressurized Inhalation Suspension (hereafter referred to as AS MDI) compared to Proventil as an active control in subjects with asthma

Trial Identifier: D6930C00002
Sponsor: AstraZeneca
NCTID:: NCT03371459
Start Date: December 2017
Primary Completion Date: March 2018
Study Completion Date: March 2018
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation

Trial Locations

Country Location
United States of America, FL Winter Park, FL, United States of America, 32789
United States of America, MA North Dartmouth, MA, United States of America, 02747
United States of America, MO St. Louis, MO, United States of America, 63141
United States of America, NC Raleigh, NC, United States of America, 27607
United States of America, OR Medford, OR, United States of America, 97504